Rectal cancer stage 3 survival rate,

rectal cancer young papilloma boron

Tema plagiatului este tot mai mult discutată în ultima vreme. Apariția unor programe performante de căutare și identificare a similitudinilor între texte [ Local recurrence after distal rectal cancer surgery is a major complication with an increased morbidity and mortality. The therapeutic strategy consists in a complex association of radiochemotherapy with surgical approach that may improve prognosis and quality of life.

It is necessary to identify the risk factors for local recurrence and to have a highly-selected patients for oncological radical treatment.

Larry: Colon Cancer Survivor

Materials and methods. The study included the analysis of 79 patients with middle and lower rectal cancer who were diagnosed and rectal cancer stage 3 survival rate at Coltea Clinic Surgical Clinic Hospital, Bucharest, for a period of 4 years.

papiloma intraductal en las mamas does human papillomavirus cause cancer

Male patients were more frequent The average age was 65 years old. The surgical strategy included 33 patients Local recurrence rate was The mean time from surgery until the time of discovery of local recurrence was Local recurrence was associated with advanced tumor stages T3 The surgical treatment strategy consisted of abdominoperineal resection, permanent colostoma and R2 resections. The radical surgical resection rectal cancer stage 3 survival rate the most significant prognostic factor.

There are a number of other patient-related factors and tumor-related factors that can significantly influence the evolution and overlall survival.

human papillomavirus infection replication cycle

Periodic clinical, imaging scans and colonoscopy follow-ups are able to early detect the tumor recurrence and to allow a curative cancer treatment. Local recurrence after mid and lower rectal cancer surgery is a major complication with direct impact on morbidity, mortality, prognosis and quality cancer metastatic in bones life of these patients.

Inoperable rectal tumour, no metastases: A   radio-chemotherapy with a favourable response surgery B   radio-chemotherapy with a non-favourable response chemotherapy Operable rectal tumour, with metastases: radical surgery of the tumour with resection of the hepatic or lung metastasis radio-chemotherapy radio-chemotherapy followed by surgical treatment. Non-operable rectal tumour with metastases: chemotherapy and radiotherapy. We must remember that the rectum is a fix organ, that represents an advantage for the irradiation process. The preoperative irradiation has the advantage of preventing the excessive irradiation of other cavity organs, as in the case of the postoperative irradiation, when the small bowel loops drop in the pelvis. This protocol has been established starting from the actual knowledge regarding the genetics of rectal cancer, and also the studies of fundamental and clinical research which analyzed the response of the rectal cancer to different treatment methods.

The treatment strategy must be established by a multidisciplinary team in order to identify carefully-selected patients to undergo the optimal oncological therapy. Keywords: rectal cancer, local recurrence, risk factors Full text  PDF.

rectal cancer stage 3 survival rate